Search results
Feb 8, 2024 · Dupixent (dupilumab) is a biologic that is given by subcutaneous (under the skin) injection which may be used to treat moderate-to-severe eczema, asthma, chronic rhinosinusitis with nasal polyposis, eosinophilic esophagitis, and prurigo nodularis.
Learn more about DUPIXENT® (dupilumab), a prescription medicine FDA-approved to treat five conditions. See how DUPIXENT® may help. Serious side effects can occur.
Oct 12, 2023 · Learn about side effects, cost, and more of Dupixent (dupilumab). It’s a prescription drug that treats atopic dermatitis (a type of eczema) and other conditions.
DUPIXENT is a biologic that works by targeting an underlying source of inflammation that could be a root cause of your uncontrolled moderate-to-severe eczema. DUPIXENT helps you stay ahead of symptoms by continuously treating eczema, even between flare-ups.
The only FDA-approved biologic for treating uncontrolled moderate-to-severe eczema in children. ages 6 months to 5 years. DUPIXENT helps you stay ahead of symptoms by continuously treating eczema between flare-ups. See how it works.
Feb 8, 2024 · Dupilumab (Dupixent) is a biologic that is given by subcutaneous (under the skin) injection that may be used to treat atopic diseases such as eczema, asthma, rhinosinusitis, eosinophilic esophagitis, and prurigo nodularis.
Jun 9, 2022 · Dupixent is a prescription medicine used: to treat adults and children 6 months of age and older with moderate-to-severe atopic dermatitis ( eczema) that is not well controlled with prescription therapies used on the skin (topical), or who cannot use topical therapies. Dupixent can be used with or without topical corticosteroids.
Apr 12, 2024 · DUPIXENT is an interleukin-4 receptor alpha antagonist indicated: Atopic Dermatitis for the treatment of adult and pediatric patients aged 6 months and older with moderate-to-severe AD whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable.
Dupilumab, sold under the brand name Dupixent, is a monoclonal antibody blocking interleukin 4 and interleukin 13, used for allergic diseases such as atopic dermatitis (eczema), asthma and nasal polyps which result in chronic sinusitis.
Feb 9, 2024 · Dupixent is an injection that is usually given under the skin every other week for the treatment of asthma, eczema, and some other inflammatory conditions. Injection site reactions and eye conditions are the most common side effects reported and, unlike several other biologics, the risk of infection is low.
